DU145
DU145 is a human prostate cancer cell line. DU145, PC3, and LNCaP are considered to be the standard prostate cancer cell lines used in therapeutic research.
The DU145 cell line was derived from a central nervous system metastasis, of primary prostate adenocarcinoma origin, removed during a parieto-occipital craniotomy. DU145 are not hormone-sensitive and do not express prostate-specific antigen. DU145 cells have moderate metastatic potential compared to PC3 cells, which have high metastatic potential. DU145 cells are androgen receptor positive.
